Cargando…
Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)()()
Oxaliplatin, in combination with 5-fluorouracil plus folinate (or capecitabine), has increased survival substantially in stage III colorectal cancer and prolonged life in stage IV patients, but its use is compromised because of severe toxicity. Chemotherapy-induced peripheral neuropathy (CIPN) is th...
Autores principales: | Karlsson, Jan Olof G., Andersson, Rolf GG, Jynge, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496205/ https://www.ncbi.nlm.nih.gov/pubmed/28668762 http://dx.doi.org/10.1016/j.tranon.2017.04.012 |
Ejemplares similares
-
May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?
por: Karlsson, Jan Olof G, et al.
Publicado: (2020) -
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013) -
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
por: Canta, Annalisa, et al.
Publicado: (2015) -
Prevention and Treatment for Chemotherapy-Induced Peripheral
Neuropathy: Therapies Based on CIPN Mechanisms
por: Hu, Lang-Yue, et al.
Publicado: (2019) -
An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN
por: Holloway, Michael P, et al.
Publicado: (2016)